Aligned Genetics Inc

NEW
XKRX:238120 (Korea (the Republic of))  
â‚© 2,920 -10 (-0.34%) Mar 27
10.18
P/B:
1.19
Market Cap:
â‚© 41.99B ($ 28.61M)
Enterprise V:
â‚© 27.31B ($ 18.61M)
Volume:
6.13K
Avg Vol (2M):
49.66K
Warning! GuruFocus detected 1 Severe warning sign with 238120. Try a 7-Day Free Trial to check it out.
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
6.13K
Market Cap â‚©:
41.99B
Market Cap $:
28.61M
10.18
Avg Vol (2M):
49.66K
Enterprise Value â‚©:
27.31B
Enterprise Value $:
18.61M
PB Ratio:
1.19
Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Aligned Genetics Inc

ISIN : KR7238120000
https://www.alignedgenetics.com
28 Simindaero 327 beon-gil, Floor 2nd and 3rd, Dongan-gu Anyang-si, Gyeonggi-do, KOR, 14055
Compare
Compare
XKRX:214610XKRX:387570XKRX:337840XKRX:398120XKRX:495900XKRX:419540XKRX:115480XKRX:290660XKRX:335810XKRX:058110ABTBSXSYKMDTXTER:SHLEWSZSE:300760DXCMXAMS:PHIASTE
Traded in other countries / regions
238120.Korea
Index Membership
KOSDAQ Composite Index
IPO Date
2016-11-03
Description
Aligned Genetics Inc is engaged in developing automated systems and imaging instruments for laboratories engaging in research with a cellular and molecular emphasis.

Financial Strength

9/10
Name Current Vs Industry Vs History
Cash-To-Debt 5.95
Equity-to-Asset 0.8
Debt-to-Equity 0.08
Debt-to-EBITDA 0.56
Interest Coverage 16.43
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.51
Distress
Grey
Safe
Beneish M-Score -2.14
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

8/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 10.3
3-Year EBITDA Growth Rate 6.5
3-Year EPS without NRI Growth Rate -1
3-Year Book Growth Rate 9.6

Momentum Rank

4/10
Name Current Vs Industry Vs History
5-Day RSI 27.16
9-Day RSI 33.49
14-Day RSI 37.39
3-1 Month Momentum % 1.31
6-1 Month Momentum % -0.48
12-1 Month Momentum % -31.83

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.48
Quick Ratio 11.27
Cash Ratio 9.3
Days Inventory 344.9
Days Sales Outstanding 53.64
Days Payable 11.66

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 1.35

Profitability Rank

5/10
Name Current Vs Industry Vs History
Gross Margin % 70.7
Operating Margin % 17.62
Net Margin % 26.16
FCF Margin % 16.87
ROE % 12.54
ROA % 9.79
ROIC % 9.98
3-Year ROIIC % -13.26
ROC (Joel Greenblatt) % 34.7
ROCE % 12.28
Years of Profitability over Past 10-Year 6

GF Value Rank

8/10
Name Current Vs Industry Vs History
PE Ratio 10.18
PE Ratio without NRI 10.07
Price-to-Owner-Earnings 16.23
PEG Ratio 0.27
PS Ratio 2.66
PB Ratio 1.19
Price-to-Tangible-Book 1.19
Price-to-Free-Cash-Flow 15.81
Price-to-Operating-Cash-Flow 13.72
EV-to-EBIT 5.8
EV-to-EBITDA 5.15
EV-to-Revenue 1.73
EV-to-FCF 10.83
Price-to-GF-Value 0.62
Price-to-Projected-FCF 1.47
Price-to-Peter-Lynch-Fair-Value 0.4
Price-to-Graham-Number 0.73
Price-to-Net-Current-Asset-Value 2.5
Price-to-Net-Cash 4.74
Earnings Yield (Greenblatt) % 17.25
FCF Yield % 6.34
Forward Rate of Return (Yacktman) % 20.25
AAPL
Income Statement Breakdown FY
Not Enough Data
AAPL
Balance Sheet Breakdown
Not Enough Data
AAPL
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Aligned Genetics Inc Executives

Details

GF Value: â‚©4724.98

XKRX:238120

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil â‚©) 15,777.579
EPS (TTM) (â‚©) 287
Beta 0.73
3-Year Sharpe Ratio -0.28
3-Year Sortino Ratio -0.38
Volatility % 18.05
14-Day RSI 37.39
14-Day ATR (â‚©) 75.562713
20-Day SMA (â‚©) 3027.5
12-1 Month Momentum % -31.83
52-Week Range (â‚©) 2575 - 4600
Shares Outstanding (Mil) 14.38

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Aligned Genetics Inc Filings

Filing Date Document Date Form
No Filing Data

Aligned Genetics Inc Stock Events

Financials Calendars
Event Date Price (â‚©)
No Event Data

Aligned Genetics Inc Frequently Asked Questions

What is Aligned Genetics Inc(XKRX:238120)'s stock price today?
The current price of XKRX:238120 is â‚©2920.00. The 52 week high of XKRX:238120 is â‚©4600.00 and 52 week low is â‚©2575.00.
When is next earnings date of Aligned Genetics Inc(XKRX:238120)?
The next earnings date of Aligned Genetics Inc(XKRX:238120) is .
Does Aligned Genetics Inc(XKRX:238120) pay dividends? If so, how much?
Aligned Genetics Inc(XKRX:238120) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.